
Jeremy Adler, MD, MSc
@jeremyadlermd
Pediatric Crohn & Colitis-ologist, health services researcher. Believer in quality science & importance of prevention. All children deserve high quality care. 〽
ID: 1465858873
http://www.chear.org 28-05-2013 22:37:53
6,6K Tweet
3,3K Followers
1,1K Following

Excellent #GUTBlog by Jeremy Adler, MD, MSc on the important paper in Gut Journal entitled "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn’s disease: post hoc analysis of the RISK study" via bit.ly/4bJFxZP Paper via


Excellent #GUTBlog by Jeremy Adler, MD, MSc on the important paper in Gut Journal entitled "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn’s disease: post hoc analysis of the RISK study" via bit.ly/4bJFxZP Paper via


#CGH4ALL Delayed⏳pediatric IBD dx👉worse long-term outcomes 📄Deep dive into the factors leading to diagnostic delays? 🔗doi.org/10.1016/j.cgh.… Summary by Nishant Aggarwal, MD Kelly Sandberg Jeanne Tung Sofia Verstraete Sabina Ali,MD Jeremy Adler, MD, MSc Jen Savas Michael Kappelman, MD, MPH @Dcharabaty


Brilliant on the podium, Dr. Stephanie Coward forecasted that in 9 Stage 3 countries, IBD incidence will reach 30 per 100,000 and prevalence 0.8% by 2025—projected to rise to 1% by 2035. A standout moment from a standout epidemiologist. #DDW2025



Digestive Disease Week American Gastroenterological Association (AGA) celebrating the Brain behind the brains at AGA, Celena Nuquay. 11 years moving up the leadership ladder at AGA and now to become the Exec Director of NASPGHAN. Lucky, lucky NASPGHAN


Special thanks to Kao-Ping Chua for his strategic data partnerships to help us learn so much more! CHEAR U-M IHPI Michigan Medicine


Excellent presentation by Perseus Patel, MD on IUS and biochemical remission in peds #IBD. BWT < 2.5, 2.4, 2.3 for UC, Ileal CD, Colon CD, respectively best cutpoints associated with calpro < 250. Stanford Childrens Center for IBD & Celiac Disease Stanford Pediatric Gastroenterology


Jeremy Adler, MD, MSc Miguel Regueiro 💯 Jeremy Adler, MD, MSc! Treat with tnf early and push levels high! 👏🏾

Jeremy Adler, MD, MSc There are many wonderful things about DDW but the very best is connecting with former trainees who are now leaders in their field! #DDW2025 #NASPGHAN #Improvecarenow


UMichGIHep-Fellowship plug - I don’t apologize (#GoBlue) Jeremy Adler, MD, MSc + team on HLA and ADA to anti-TNF AJG - The American Journal of Gastroenterology ACG 👇🏾 ▶️HLA+ —> trend toward ADA+ in kids. Similar to adults! journals.lww.com/ajg/abstract/2…

This is an excellent resource. Thank you Ildiko ☕️ Flat Jennie (Jennie David, Ph.D.) ICN PAC ImproveCareNow™ and everyone for putting this together.

In the #RedJournal: HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease Adler, et al. 📕 bit.ly/4mkeaKL Jeremy Adler, MD, MSc Athos Bousvaros


I'm looking forward to the Official TOpClass Consortium meeting on perianal Crohn's disease. I'm sorry I can't be there in person. sayso.health/events/topclas…


Thank you Official TOpClass Consortium for an excellent meeting on perianal Crohn's disease. Multidisciplinary care clearly is important. Wonderful collaborative effort! We have made a lot of progress, but need better evidence, more high-quality research - particularly in pediatrics.


Dr. Reeves shares insights on Sickle Cell Disease care and the role of the MiSCDC Program in identifying service gaps and outcomes. Sarah Reeves U-M IHPI C.S. Mott Children's Mott Children's MD ihpi.umich.edu/news-events/ne…

🔍 Perianal pain/discharge? 📉 This study found no link between symptoms and lesions—highlighting the need for routine perianal exams in pediatric Crohn’s disease. 🔗 doi.org/10.1002/jpn3.7… #pediatrics #pedsgi #ibd Jeremy Adler, MD, MSc Blake Hardin

